Nichola Webster

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

Stuart Lacy, Sharon Barrans, Philip Beer et al. · Blood · 2020 · 481 citations · Full text

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

Talha Munir, David A. Cairns, Adrian Bloor et al. · New England Journal of Medicine · 2023 · 138 citations · Full text

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Peter Hillmen, Alexandra Pitchford, Adrian Bloor et al. · The Lancet Oncology · 2023 · 92 citations · Full text

Hematological Malignancy, Interim Analysis, Lymphoid Neoplasia +11

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network

Simon Crouch, Daniel Painter, Sharon Barrans et al. · Blood Advances · 2022 · 33 citations · Full text

United Kingdom ’, Genetics, Immunology +21

Continued Long Term Responses to Ibrutinib + Venetoclax Treatment for Relapsed/Refractory CLL in the Blood Cancer UK TAP Clarity Trial

Peter Hillmen, Rebecca H. Boucher, Nichola Webster et al. · Blood · 2020 · 17 citations